Register Now
Course Information

Join us for Advancing Cardiovascular Care: Current and Evolving Management Strategies.

Cardiovascular (CV) medicine is a rapidly evolving discipline. Research studies and clinical trials are continually expanding the evidence base related to the assessment, diagnosis, and treatment of patients with CV disease. In addition, new technologies, new drugs, and new devices are expanding the therapeutic choices available to clinicians.

The volume and complexity of the data being generated combined with the expanded technologies make it difficult for busy CV specialists to remain up to date on knowledge of the data and the implications for clinical practice. This educational activity is designed for busy clinicians by providing a review and analysis of new research and technical advances and assessing their potential impact on management of patients in clinical practice. 

Why Attend This Symposium?

  • Hear cutting-edge updates and research on the management of cardiovascular disease
  • Earn CME and ABIM Maintenance of Certification Points
  • Learn from leading experts in the field of cardiovascular medicine and surgery
  • Explore our exhibit hall

After completing this activity, participants will be able to:

  • Describe innovations in the use of risk markers and artificial intelligence to assess cardiovascular risk.
  • Critically appraise the efficacy and adverse event profiles of therapies designed to mitigate CV risk. 
  • Detail the current management strategies for patients with heart failure, including those with cardiogenic shock and heart failure with preserved ejection fraction.     
  • Summarize the evidence on mitral and tricuspid disease management, including mitral clip technologies, mitral regurgitation, and tricuspid repair, and describe their use in clinical practice.
  • Analyze the evidence on the diagnosis and management of patients with aortic dissection, aneurysm, and ascending aortic disease.
  • Describe the patient selection, repair techniques, and surgical therapies for managing patients with aortic valve disease.
  • Review the recent evidence on emerging device technologies for leadless pacemaker, ventricular arrhythmia management, ventricular tachycardia ablation, and left atrial appendage closure.  

Who Should Attend?

The course is directed to physicians, physician assistants, and nurses with an interest in cardiovascular medicine and surgery.